Cipla Icatibant (Icatibant)
icatibant 30 mg/3 mL injection, 3 mL syringe · INJECTION · PBS code 1976B
AUTHORITY_REQUIREDWhat it costs
AU$420.88 PBS-determined price per 1 units
Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.
- • First listed on the PBS: 2020-10-01.
- • Repeats: 1.
- • PBS program: GE.
Eligibility criteria for subsidised access
The following is the government's own wording from the PBS Schedule, shown unchanged.
Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1
Anticipated emergency treatment of an acute attack of hereditary angioedema
Initial
Patient must have confirmed diagnosis of C1-esterase inhibitor deficiency; AND
Patient must have been assessed to be at significant risk of an acute attack of hereditary angioedema; AND
The condition must be assessed by a clinical immunologist; or
The condition must be assessed by a respiratory physician; or
The condition must be assessed by a specialist allergist; or
The condition must be assessed by a general physician experienced in the management of patients with hereditary angioedema.
The name of the specialist consulted must be provided at the time of application for initial supply.
The date of the pathology report and name of the Approved Pathology Authority must be provided at the time of application.
Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 2
Increased maximum quantities will be limited to 12 injections per authority prescription.
Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1
Anticipated emergency treatment of an acute attack of hereditary angioedema
Continuing
Patient must have previously received PBS-subsidised treatment with this drug for this condition.
Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 2
Increased maximum quantities will be limited to 12 injections per authority prescription.
Sponsor: Cipla Australia Pty Ltd ABN 46 132 155 063
Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.
Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.